• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL2300639 注射用重组人凝血因子Ⅷ-Fc融合蛋白 Recombinant Human Coagulation Factor VIII-Fc Fusion Protein Lyophilized Biological Products(2.4) New Drug Application 2023-09-21 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CXSL2300638 注射用重组人凝血因子Ⅷ-Fc融合蛋白 Recombinant Human Coagulation Factor VIII-Fc Fusion Protein Lyophilized Biological Products(2.4) New Drug Application 2023-09-21 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CXSS2300045 注射用重组人凝血因子Ⅷ-Fc融合蛋白 Recombinant Human Coagulation Factor VIII-Fc Fusion Protein Lyophilized Biological Products(1) New Drug Application 2023-06-21 view
CXSS2300044 注射用重组人凝血因子Ⅷ-Fc融合蛋白 Recombinant Human Coagulation Factor VIII-Fc Fusion Protein Lyophilized Biological Products(1) New Drug Application 2023-06-21 view
CXSS2101084 注射用重组人凝血因子Ⅷ-Fc融合蛋白 Recombinant Human Coagulation Factor VIII-Fc Fusion Protein Lyophilized Biological Products(1) New Drug Application 2021-12-23 view
CXSS2101083 注射用重组人凝血因子Ⅷ-Fc融合蛋白 Recombinant Human Coagulation Factor VIII-Fc Fusion Protein Lyophilized Biological Products(1) New Drug Application 2021-12-23 view
CXSL1700163 注射用重组人凝血因子Ⅷ-Fc融合蛋白 Recombinant Human Coagulation Factor VIII-Fc Fusion Protein Lyophilized Biological Products(1) New Drug Application 2018-03-09 开封制药(集团)有限公司 Kaifeng Pharmaceutical (GROUP) Co Ltd Certificate Issued 2018-09-25 view
CXSL1700162 注射用重组人凝血因子Ⅷ-Fc融合蛋白 Recombinant Human Coagulation Factor VIII-Fc Fusion Protein Lyophilized Biological Products(1) New Drug Application 2018-03-09 开封制药(集团)有限公司 Kaifeng Pharmaceutical (GROUP) Co Ltd Certificate Issued 2018-09-25 view